Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 1
2006 2
2007 1
2008 1
2011 1
2014 1
2015 3
2016 5
2017 4
2018 5
2019 5
2020 3
2021 4
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome.
Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, Hollenstein M, Shoumariyeh T, Skos L, Reiter B, Gerner MC, Spannbauer A, Hasimbegovic E, Schmidl D, Garhöfer G, Gyöngyösi M, Schmetterer KG, Gerner C. Kovarik JJ, et al. Among authors: reiter b. iScience. 2023 Jan 20;26(1):105717. doi: 10.1016/j.isci.2022.105717. Epub 2022 Dec 5. iScience. 2023. PMID: 36507225 Free PMC article.
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.
Franchi F, Ortega-Paz L, Rollini F, Galli M, Been L, Ghanem G, Shalhoub A, Ossi T, Rivas A, Zhou X, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Reiter B, Jilma B, Angiolillo DJ. Franchi F, et al. Among authors: reiter b. JACC Cardiovasc Interv. 2023 Jan 9;16(1):36-46. doi: 10.1016/j.jcin.2022.10.034. Epub 2022 Oct 31. JACC Cardiovasc Interv. 2023. PMID: 36317958 Free article. Clinical Trial.
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study.
Franchi F, Rollini F, Ortega-Paz L, Been L, Giordano S, Galli M, Ghanem G, Garabedian H, Al Saleh T, Uzunoglu E, Rivas A, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Mahowald M, Reiter B, Jilma B, Angiolillo DJ. Franchi F, et al. Among authors: reiter b. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2528-2539. doi: 10.1016/j.jcin.2023.08.009. Epub 2023 Aug 21. JACC Cardiovasc Interv. 2023. PMID: 37609698 Clinical Trial.
Prasugrel in critically ill patients.
Schoergenhofer C, Hobl EL, Staudinger T, Speidl WS, Heinz G, Siller-Matula J, Zauner C, Reiter B, Kubica J, Jilma B. Schoergenhofer C, et al. Among authors: reiter b. Thromb Haemost. 2017 Aug 1;117(8):1582-1587. doi: 10.1160/TH17-03-0154. Epub 2017 Jul 6. Thromb Haemost. 2017. PMID: 28692105 Free PMC article. Clinical Trial.
Quantification of Drugs in Brain Samples.
Reiter B, Stimpfl T. Reiter B, et al. J Anal Toxicol. 2015 Nov-Dec;39(9):702-6. doi: 10.1093/jat/bkv078. Epub 2015 Jul 30. J Anal Toxicol. 2015. PMID: 26232450
Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers.
Bergmann F, Wulkersdorfer B, Oesterreicher Z, Bauer M, Al Jalali V, Nussbaumer-Pröll A, Wölfl-Duchek M, Jorda A, Lackner E, Reiter B, Stimpfl T, Ballarini N, König F, Zeitlinger M. Bergmann F, et al. Among authors: reiter b. J Antimicrob Chemother. 2022 Oct 28;77(11):3086-3092. doi: 10.1093/jac/dkac285. J Antimicrob Chemother. 2022. PMID: 36039038 Clinical Trial.
Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin.
Oesterreicher Z, Eberl S, Wulkersdorfer B, Matzneller P, Eder C, van Duijn E, Vaes WHJ, Reiter B, Stimpfl T, Jäger W, Nussbaumer-Proell A, Marhofer D, Marhofer P, Langer O, Zeitlinger M. Oesterreicher Z, et al. Among authors: reiter b. Clin Pharmacokinet. 2022 May;61(5):697-707. doi: 10.1007/s40262-021-01091-1. Epub 2022 Jan 7. Clin Pharmacokinet. 2022. PMID: 34997559 Free PMC article.
Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies.
Leutner M, Butylina M, Matzhold C, Klimek P, Cuhaj C, Bellach L, Baumgartner-Parzer S, Reiter B, Preindl K, Kautzky A, Stimpfl T, Thurner S, Pietschmann P, Fürnsinn C, Kautzky-Willer A. Leutner M, et al. Among authors: reiter b. Biomed Pharmacother. 2023 Feb;158:114089. doi: 10.1016/j.biopha.2022.114089. Epub 2022 Dec 18. Biomed Pharmacother. 2023. PMID: 36538862 Free article.
42 results